Keywords: توسعه دارویی; Alzheimer's disease; dementia; innovation; pricing; drug pipeline; drug development;
مقالات ISI توسعه دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: توسعه دارویی; Electrolyte abnormalities; Phase I clinical trials; Drug development;
Keywords: توسعه دارویی; Hepatocellular carcinoma; Immunotherapy; Drug development; Management; Review;
Keywords: توسعه دارویی; opioids; abuse-deterrent formulations of opioid analgesics; chronic pain; drug development; payer reimbursement;
Keywords: توسعه دارویی; Anti-tumor immunity; Immune suppression; Immune memory; Drug development; Anti-cancer drug scheduling; DC; dendritic cell; ICD; immunogenic cell death; IFN; interferon; MEDIC; medium-dose intermittent chemotherapy; MTD; maximum tolerated dose; NK; natural
Keywords: توسعه دارویی; Non-alcoholic fatty liver disease; High-content screening; Lipid droplets; LOPAC; CREB1; Drug development;
Keywords: توسعه دارویی; UWQADRQFXJNEOZ-UHFFFAOYSA-N; KWOVKARWDHUSIN-UHFFFAOYSA-N; ZHGWZQOAJKLQEL-UHFFFAOYSA-N; KMAVUSDAUUUVLI-UHFFFAOYSA-N; SIMUFWJFAOUTGX-UHFFFAOYSA-N; YJCQPBKHHGIVPY-UHFFFAOYSA-N; GWCAFEYJDZYUAU-UHFFFAOYSA-N; LQSGBWREJUGOBD-UHFFFAOYSA-N; PDOISTVVCHXKAI-UHFFFAOY
Keywords: توسعه دارویی; Celiac; Nonceliac gluten sensitivity; Gluten; Nutritional deficiencies; Gluten-free diet; Drug development;
Keywords: توسعه دارویی; Alzheimer's; Pipeline; Clinicaltrials.gov; Biomarkers; Drug development; Clinical trials; Monoclonal antibodies; Amyloid; Tau; Alzheimer's disease drug development pipeline: 2018;
Keywords: توسعه دارویی; Mast cells; Mastocytosis; KIT mutations; Advanced disease; Tyrosine kinase inhibitors; Targeted drugs; Drug development;
Keywords: توسعه دارویی; CSA; chondrasarcoma; FSA; fibrosarcoma; GI; gastrointestinal tract; GIST; gastrointestinal stromal tumors; GWAS; genome wide association studies; HS; histiocytic sarcoma; HSA; hemangiosarcoma; IHC; immunohistochemistry; LIP; liposarcoma; LMY; leiomyosarco
Keywords: توسعه دارویی; Animal model; Drug development; Glomerular filtration rate; Kidney disease; Methods;
Keywords: توسعه دارویی; Cancer; Drug development; Surrogates;
Keywords: توسعه دارویی; Drug impurities; Drug development; Process impurities; Stress studies; Forced degradation; Monoclonal antibody impurities; Monoclonal antibody purification;
Keywords: توسعه دارویی; Staphylococcus aureus; Anti-Biofilm; Drug development; Mechanism;
Keywords: توسعه دارویی; Ranalexin; Antimicrobial peptide; Lipopeptide; Positron emission tomography; Multiresistant bacteria; Drug development;
Keywords: توسعه دارویی; Ion channels; Lysosomes; Cancer; Metastasis; Chemotherapy; Drug development; Trpml; TPCs; BK channels; ClC-7; TMEM175;
Keywords: توسعه دارویی; Toxicogenomics; Drug development; Drug discovery; Drug safety; Predictive toxicology;
Keywords: توسعه دارویی; Fused 4-aryl-4H-chromenes; Microtubule inhibitors; Anti-Proliferation; Anti-angiogenesis; Drug development;
Keywords: توسعه دارویی; Breast cancer stem cells; Natural products; Cancer therapy; Drug development;
Keywords: توسعه دارویی; Ionic liquids; Ionic interactions; Biological activity; Toxicity; Drug development;
Keywords: توسعه دارویی; Thyroid hormone; Evolution; Development; Signaling; Metabolite; Signal transduction; Stem cell; Endocrine system; Drug development; Target discovery;
Keywords: توسعه دارویی; Tuberculosis (TB); Modeling; Simulation; Pharmacokinetic/pharmacodynamics (PK/PD); Drug development; Translational science;
Keywords: توسعه دارویی; Drug development; Drug discovery; Translational research; Valley of death; Psychiatric disorders; Dimensional approach; Education;
Keywords: توسعه دارویی; Liver fibrosis; Chronic liver disease (CLD); Hepatic stellate cells (HSC); Anti-fibrotic drug; Drug development; In-vitro models;
Keywords: توسعه دارویی; Tegumentary leishmaniasis; Proteomics; Leishmania; Drug development;
Keywords: توسعه دارویی; Social media; digital health; drug development; clinical trials; online communities; smartphone applications;
Keywords: توسعه دارویی; Efficacy; Drug development; Cancer; Animal studies; In vitro studies; Monoclonal antibodies; Anticancer medicines; Clinical development; Preclinical studies;
Keywords: توسعه دارویی; Forced swim test; PK/PD modelling; Drug development; Antidepressant, quantitative translation;
Keywords: توسعه دارویی; Breast cancer; Mastectomy; Mouse; Model; Drug development; Metastasis;
Keywords: توسعه دارویی; tuberculosis; natural product; drug development; clinical trial;
Keywords: توسعه دارویی; Paediatric haematology and oncology; Early phase clinical trials; Drug development; Personalised medicine; OncologÃa y hematologÃa pediátrica; Ensayos clÃnicos precoces; Desarrollo de nuevos fármacos; Medicina personalizada;
Keywords: توسعه دارویی; 5HTT; serotonin transporter; BD; bipolar disorder; BDNF; brain-derived neurotrophic factor; COMT; catechol-O-methyltransferase; GEM; genome-scale model of metabolism; MAO-A; monoamine oxidase A; UD; unipolar disorder; Affective disorder; Bipolar disorder;
Keywords: توسعه دارویی; Acyl glucuronide; Drug development; Drug toxicity; In vitro screening; In vivo model; Immune activation; Protein adduct; Reactive metabolite; UDP-glucuronosyltransferase; ADR; adverse drug reaction; AG; acyl glucuronide; AGE; advanced glycation end prod
Keywords: توسعه دارویی; Drug development; Drug delivery; Adherence; Inhaled corticosteroids; Long-acting β-agonists; Tiotropium; Biologics; Omalizumab;
Keywords: توسعه دارویی; Endometriosis; New drugs; Drug development; Elagolix; Clinical trials;
Keywords: توسعه دارویی; Traditional Chinese medicine; Western medicine; Artemisinin; Evidence-based traditional medicines; Drug development; Quality control;
Keywords: توسعه دارویی; Drug development; Enterohepatic circulation; Salt selection; Stability; Solid-state;
Keywords: توسعه دارویی; Protein-protein interfaces; Mutations; Drug development; Protein stability; Protein interaction;
Keywords: توسعه دارویی; Cytokines; Signal transduction; Drug development; Inflammation; Autoimmunity; Therapy; JAK; Janus Kinase; STAT; Signal transducer and activator of transcription; NF-kB; nuclear factor kappa-light-chain-enhancer of activated B cells; MAPK; Mitogen activate
Keywords: توسعه دارویی; drug development; innovation; pediatric; policy;
Keywords: توسعه دارویی; Influenza A virus; Host targets; H5N1; Hyper immune reaction; Drug development;
Keywords: توسعه دارویی; clinical trial; drug development; site-less;
Keywords: توسعه دارویی; L24; L25; L65; D22; Demand uncertainty; Drug development; Dynamics; Profit uncertainty; Pharmaceutical industry; Research and development cooperation; Technological uncertainty; R&D markets;
Keywords: توسعه دارویی; SCZ; Schizophrenia; GWAS; Genome-wide association studies; CNVs; Copy number variants; Psychosis; Schizophrenia; Antipsychotics; Glutamate; Dopamine; Clinical trials; Efficacy; Drug development; Pharmacology;
Keywords: توسعه دارویی; Drug development; Drug discovery; Enzyme; Ion channel; Off-target; Receptor; Safety pharmacology; Side effect; Toxicology; Transporter;
Keywords: توسعه دارویی; CGRP; calcitonin gene related peptide; CSD; cortical spreading depression; NSAIDs; non-steroidal anti-inflammatory drugs; 5-HT; 5-hydroxytryptamine; 5-HIAA; 5-hydroxyindoleacetic acid; NO; nitric oxide (NO); TG; trigeminal ganglion; TNC; trigeminal nucleu
Keywords: توسعه دارویی; Short selling; Drug development; FDA announcements; Insider trading; Private information;
Keywords: توسعه دارویی; Safety biomarkers; Regulatory qualification; Evidentiary standards; Drug development; FDA; US Food and Drug Administration; EMA; European Medicines Agency; PMDA; Pharmaceuticals and Medical Devices Agency of Japan; FNIH; Foundation for the National Instit
Keywords: توسعه دارویی; TB; tuberculosis; MTB; Mycobacterium tuberculosis; MDR-TB; multi-drug resistant tuberculosis; XDR-TB; extensively drug resistant tuberculosis; TDR-TB; totally drug resistant tuberculosis; INH; isoniazid; WHO; World Health Organization; RIF; rifampicin; PZ